1   Preface
2   Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Neurostimulation Devices Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Stimulation Type
    6.1    Internal Stimulation
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    External Stimulation
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Device Type
    7.1    SCS (Spinal Cord Stimulation) Devices
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    DBS (Deep Brain Stimulation) Devices
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    SNS (Sacral Nerve Stimulation) Devices
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    VNS (Vagus Nerve Stimulation) Devices
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5     GES (Gastric Electrical Stimulation) Devices
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Transcutaneous Electrical Nerve Stimulation Devices
        7.6.1 Market Trends
        7.6.2 Market Forecast
    7.7    Transcranial Magnetic Stimulation Devices
        7.7.1 Market Trends
        7.7.2 Market Forecast
    7.8    Others
        7.8.1 Market Trends
        7.8.2 Market Forecast
8   Market Breakup by Application
    8.1    Pain Management
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Epilepsy
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Essential Tremors
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Urinary and Fecal Incontinence
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Depression
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    Dystonia
        8.6.1 Market Trends
        8.6.2 Market Forecast
    8.7    Parkinson’s Disease
        8.7.1 Market Trends
        8.7.2 Market Forecast
    8.8    Others
        8.8.1 Market Trends
        8.8.2 Market Forecast
9   Market Breakup by End-User
    9.1    Rehabilitation Centers
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Hospitals
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Medical Clinics
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Others
        9.4.1 Market Trends
        9.4.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Europe
        10.2.1 Germany
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 France
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 United Kingdom
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 Italy
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Spain
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Russia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Asia Pacific
        10.3.1 China
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 Japan
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 India
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 South Korea
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Australia
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Indonesia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
    12.1    Overview
    12.2    Inbound Logistics
    12.3    Operations
    12.4    Outbound Logistics
    12.5    Marketing and Sales
    12.6    Post Sales Services
13  Porters Five Forces Analysis
    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Indicators
15  Competitive Landscape
    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Biocontrol Medical
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
        15.3.2    Boston Scientific Corporation
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    Cyberonics Inc.
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
        15.3.4    Medtronic Inc.
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
        15.3.5    Neuronetics Inc.
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
        15.3.6    Neuropace Inc.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
        15.3.7    Neurosigma Inc.
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
        15.3.8    Nevro Corporation
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
        15.3.9    ST. Jude Medical Inc.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
        15.3.10    Synapse Biomedical Inc.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio 
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer



 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			